Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Artificial Intelligence1 month agoTop 5 Interesting Things AI Did This Month – September 2026 Edition
-
Fashion4 weeks agoLuxury Watches That Could Appreciate Over the Next Decade [2026 Auction Buyer Guide]
-
Economy4 weeks agoOER Magazine September Edition 2026
-
Banking & Finance2 months agoThe GCC’s 10 Richest Billionaires: Inside US$253.5 Billion of Wealth
-
Alamaliktistaad Magazines3 weeks agoAlam Al-Iktisaad Magazine September 2026 Edition
-
Banking & Finance1 month agoINVESTIGATION: What If You Bought Apple Stock Every Time You Bought an iPhone?
-
News2 months agoOPEC+ Holds Output Steady for October as Focus Shifts to 2027 Quotas
-
Artificial Intelligence1 month agoWhat the World’s Top 10 Tech CEOs Really Earn
